This finding could explain the effect of PFKFB4 overexpression in some cancer cells, such as the transcription of a key non-oxidative enzyme of the PPP and the redirection of glycolytic intermediates to the non-oxidative arm of PPP. The gene discussed is PFKFB4; the disease is cancer.